Subscribe To

Price Alert Latest News Economic Calendar News

DOCU / DocuSign analysts still say ‘sell' as tough macro conditions weigh

DocuSign Inc's comments about a still-tough macro environment, with weakness in enterprise and a deceleration of billings growth in the second half of the year, have soured the opinion of UBS analysts despite the e-signature product provider posting “solid” second-quarter fiscal 2024 financial results. In a note to clients, they maintained their ‘Sell' rating on the stock but have raised their 12-month target price on DocuSign shares from $44 to $48. Read More

Demo Live Account See Partner Details

Content Topics

Docusign

Analysts

Still

Sell

Tough

Macro

Conditions

sell

Stock

DOCU

Posted: Sep 8 2023, 15:21

Author Name: Proactive Investors

DOCU News

By Zacks Investment Research
November 1, 2023

DocuSign (DOCU) Stock Sinks As Market Gains: Here's Why

DocuSign (DOCU) closed at $38.69 in the latest trading session, marking a -0.49% move from the prior day.

By Seeking Alpha
October 16, 2023

DocuSign: Buy The Dip Aggressively

DocuSign's promising FQ2'24 performance warrants another upgrade in our rating to a Buy, especially made sweeter by the improved upside potential from

By Zacks Investment Research
October 2, 2023

Here's Why DocuSign (DOCU) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

By The Motley Fool
September 29, 2023

1 Growth Stock Down 86% You'll Regret Not Buying on the Dip

DocuSign's digital document technology made its stock extremely popular among investors at the height of the pandemic. But as society returned to norm

By Yahoo Finance
September 16, 2023

AI can 'take out a lot of friction' in drafting workflows: DocuSign CEO

Electronic signature company DocuSign (DOCU) sees significant revenue gains in its second-quarter earnings, with CEO Allan Thygesen looking forward to

By The Motley Fool
September 13, 2023

DocuSign Stock: Bear vs. Bull

DocuSign's Q2 earnings report topped Wall Street's expectations. Its top-line growth remains sluggish but its margins are stabilizing.

By Seeking Alpha
September 11, 2023

DocuSign: Buy While The Market Is Looking The Other Way (Ratings Upgrade)

DocuSign's shares have fallen more than 10% this year, trading at a lower valuation than in 2019. Despite recent macro-driven slowdowns, DocuSign is s

By The Motley Fool
September 10, 2023

Is DocuSign Stock Finally On the Road to Recovery After Its Spectacular Fall from Grace?

DocuSign delivered a beat and raise quarter, but growth remains anemic. The company is making progress but has yet to capitalize on its contract lifec

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.